Scott Wolchko | President and Chief Executive Officer |
Wayne Chu | Chief Medical Officer |
Ed Dulac | Chief Financial Officer |
Bob Valamehr | Chief Research and Development Officer |
Michael Yee | Jefferies |
Ashiq Mubarack | Citi |
Daina Graybosch | SVB Leerink |
Kelsey Goodwin | Guggenheim |
Nick Abbott | Wells Fargo |
Matt Biegler | Oppenheimer |
Robyn Karnauskas | Truist Securities |
David Dai | SMBC |
Peter Lawson | Barclays |
Welcome to the Fate Therapeutics Fourth Quarter 2021 Financial Results Conference Call. [Operator Instructions] This call is being webcast live on the Investors section of Fate’s website at fatetherapeutics.com.
As a reminder, today’s call is being recorded. I would now like to introduce Scott Wolchko, President and CEO of Fate Therapeutics.
Thank you.